Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prognosis of Covid-19 Infection Among Opium Users in Iran,2020: A Hospital-Based Study Publisher



Mirahmadizadeh A1 ; Maleki Z2 ; Miyar A3 ; Sahebi R4 ; Dadvar A5 ; Moradian MJ6, 7 ; Rastegarfar B6 ; Daliri M2 ; Mohammadi Abnavi M2 ; Ghaem H8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Student Research committee, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Schulich School of Medicine and Dentistry, University of Western Ontario (Western University), London, ON, Canada
  4. 4. Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran
  5. 5. Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Disaster Public Health, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
  8. 8. Non-Communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Journal of Substance Use Published:2024


Abstract

Introduction: Since Iran has the highest opioid consumption in the world and the literature surrounding the association of COVID-19 with opioid consumption is still insufficient, in this study, we aimed to present the individual, clinical, and outcome characteristics of patients with COVID-19 disease who had a history of opium use. Methods: In this cross-sectional study, 1,985 patients, with a history of opium consumption, who were admitted to hospital because of COVID-19 disease were evaluated. Data were obtained from February 24, 2020 to June 21 2021, using the Medical Care Monitoring Center (MCMC) system of Shiraz University of Medical Sciences located in the province of Fars. Results: The mean age of patients was 57.3 ± 17.1 years. The most common symptoms of COVID-19 disease were loss of consciousness (77.4%). 25% of patients had underlying diseases, the most common of which were cardiovascular disease (21.4%) and hypertension (21.2%). Out of 1,985 patients 251 (12.6%) died due to COVID-19. Multiple logistic regression showed that age, gender, having underlying diseases and high-resolution (HRCT) of lung are associated with mortality. Conclusion: Our results showed, age 40–59 years, male gender, presence of underlying disease(s) and HRCT of the lung with finding, are correlated to the mortality of COVID-19 hospitalized patients with a history of opium consumption. © 2022 Taylor & Francis Group, LLC.
Related Docs
1. Risk of Covid-19 Infection and the Associated Hospitalization, Icu Admission and Mortality in Opioid Use Disorder: A Systematic Review and Meta-Analysis, Addiction Science and Clinical Practice (2022)
2. Methodological Paper: Covid-19 and Substance Use Disorder: Study Protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global Survey, Basic and Clinical Neuroscience (2020)
Experts (# of related papers)
View all Related Experts
Ali Farhoudian (1)
Behnam Behnoush (1)